PKS Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
PKS Advisory Services's BMY Position: Q1 2026 in Review
PKS Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 0.44% in Q1 2026, buying an estimated $1.4K and bringing the position to 5,504 shares worth $334K. The position accounts for 0.08% of the portfolio, ranked #195.
PKS Advisory Services first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $349K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- PKS Advisory Services held 5,504 shares of Bristol-Myers Squibb worth $334K as of Q1 2026.
- PKS Advisory Services bought 24 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.4K.
- Bristol-Myers Squibb made up 0.08% of PKS Advisory Services's portfolio in Q1 2026, its #195 holding.
- PKS Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- PKS Advisory Services's Bristol-Myers Squibb position peaked at $349K in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on PKS Advisory Services's 13F filing for Q1 2026, filed 13 May 2026.